Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arijit Ganguli

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Current Medical Research and Opinion|September 9, 2017
Psychometric evaluation of the Rheumatoid Arthritis Symptom Questionnaire (RASQ) in an observational studyBenjamin Banderas, Martha Skup, Alan L Shields, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 19, 2012
The impact of second-line agents on patients' health-related quality of life in the treatment for non-small cell lung cancer: a systematic reviewArijit Ganguli, Phillip Wiegand, Xin Gao, et al.
Clinical Therapeutics|April 6, 2016
Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid ArthritisKeith A Betts, Jenny Griffith, Arijit Ganguli, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 22, 2015
Reliability and Validity of the Work Instability Scale for Rheumatoid ArthritisDennis Revicki, Arijit Ganguli, Miriam Kimel, et al.
Current Medical Research and Opinion|August 22, 2019
Economic burden of fatigue or morning stiffness among patients with rheumatoid arthritis: a retrospective analysis from real-world dataVibeke Strand, Ruchitbhai Shah, Chris Atzinger, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 23, 2021
Patient-reported outcomes from the phase II FAST trial of zolbetuximab plus EOX compared to EOX alone as first-line treatment of patients with metastatic CLDN18.2+ gastroesophageal adenocarcinomaFlorian Lordick, Salah-Eddin Al-Batran, Arijit Ganguli, et al.
Journal of Medical Economics|April 26, 2022
Cost-effectiveness of enzalutamide versus apalutamide versus androgen deprivation therapy alone for the treatment of metastatic castration-sensitive prostate cancer in CanadaFred Saad, Andrew Chilelli, Benny Hui, et al.
JAMA Ophthalmology|September 9, 2016
Prevalence of Noninfectious Uveitis in the United States: A Claims-Based AnalysisJennifer E Thorne, Eric Suhler, Martha Skup, et al.
Health and Quality of Life Outcomes|December 21, 2019
Further content validation of the 18-item NCCN/FACT Ovarian Symptom Index and its Disease Related Symptom-Physical (DRS-P) subscale for use in advanced ovarian cancer clinical trialsSara Shaunfield, Sally Jensen, Allison P Fisher, et al.
Arthritis Research & Therapy|June 1, 2018
Comparison of US patient, rheumatologist, and dermatologist perceptions of psoriatic disease symptoms: results from the DISCONNECT studyM Elaine Husni, Anthony Fernandez, Brett Hauber, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Current Medical Research and Opinion|September 9, 2017
Psychometric evaluation of the Rheumatoid Arthritis Symptom Questionnaire (RASQ) in an observational studyBenjamin Banderas, Martha Skup, Alan L Shields, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 19, 2012
The impact of second-line agents on patients' health-related quality of life in the treatment for non-small cell lung cancer: a systematic reviewArijit Ganguli, Phillip Wiegand, Xin Gao, et al.
Clinical Therapeutics|April 6, 2016
Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid ArthritisKeith A Betts, Jenny Griffith, Arijit Ganguli, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 22, 2015
Reliability and Validity of the Work Instability Scale for Rheumatoid ArthritisDennis Revicki, Arijit Ganguli, Miriam Kimel, et al.
Current Medical Research and Opinion|August 22, 2019
Economic burden of fatigue or morning stiffness among patients with rheumatoid arthritis: a retrospective analysis from real-world dataVibeke Strand, Ruchitbhai Shah, Chris Atzinger, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 23, 2021
Patient-reported outcomes from the phase II FAST trial of zolbetuximab plus EOX compared to EOX alone as first-line treatment of patients with metastatic CLDN18.2+ gastroesophageal adenocarcinomaFlorian Lordick, Salah-Eddin Al-Batran, Arijit Ganguli, et al.
Journal of Medical Economics|April 26, 2022
Cost-effectiveness of enzalutamide versus apalutamide versus androgen deprivation therapy alone for the treatment of metastatic castration-sensitive prostate cancer in CanadaFred Saad, Andrew Chilelli, Benny Hui, et al.
JAMA Ophthalmology|September 9, 2016
Prevalence of Noninfectious Uveitis in the United States: A Claims-Based AnalysisJennifer E Thorne, Eric Suhler, Martha Skup, et al.
Health and Quality of Life Outcomes|December 21, 2019
Further content validation of the 18-item NCCN/FACT Ovarian Symptom Index and its Disease Related Symptom-Physical (DRS-P) subscale for use in advanced ovarian cancer clinical trialsSara Shaunfield, Sally Jensen, Allison P Fisher, et al.
Arthritis Research & Therapy|June 1, 2018
Comparison of US patient, rheumatologist, and dermatologist perceptions of psoriatic disease symptoms: results from the DISCONNECT studyM Elaine Husni, Anthony Fernandez, Brett Hauber, et al.
Pageof 7